Recurrent Breast Cancer Active Not Recruiting Phase 2 Trials for Tamoxifen (DB00675)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02269670Phase II Study of Everolimus Beyond ProgressionTreatment